Serological assays for emerging coronaviruses: Challenges and pitfalls
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aburizaiza, 2014, Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012, The Journal of infectious diseases, 209, 243, 10.1093/infdis/jit589
Annan, 2013, Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe, Emerg. Infect. Dis., 19, 456, 10.3201/eid1903.121503
Bermingham, 2012, Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 17, 20290
Bradburne, 1970, Antigenic relationships amongst coronaviruses, Arch. Gesamte Virusforsch., 31, 352, 10.1007/BF01253769
Buchholz, 2013, Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October–November 2012, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 18
Buchholz, 2004, Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity, Proc. Natl. Acad. Sci. U.S.A., 101, 9804, 10.1073/pnas.0403492101
Burbelo, 2012, Serology-enabled discovery of genetically diverse hepaciviruses in a new host, J. Virol., 86, 6171, 10.1128/JVI.00250-12
Carattoli, 2005, Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS, J. Med. Virol., 76, 137, 10.1002/jmv.20338
Chan, 2009, Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus, J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol., 45, 54, 10.1016/j.jcv.2009.02.011
Chan, 2013, Cross-reactive antibodies in convalescent SARS patients’ sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests, J. Infect., 67, 130, 10.1016/j.jinf.2013.03.015
Chan, 2004, Detection of SARS coronavirus in patients with suspected SARS, Emerg. Infect. Dis., 10, 294, 10.3201/eid1002.030610
Chan, 2004, Immunofluorescence assay for serologic diagnosis of SARS, Emerg. Infect. Dis., 10, 530, 10.3201/eid1003.030493
Che, 2005, Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43, J. Infect. Dis., 191, 2033, 10.1086/430355
Chen, 2004, Serology of severe acute respiratory syndrome: implications for surveillance and outcome, J. Infect. Dis., 189, 1158, 10.1086/380397
Chen, 2004, Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein, Clin. Chem., 50, 988, 10.1373/clinchem.2004.031096
Corman, 2012, Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 17
Corman, 2012, Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 17
Dijkman, 2012, The dominance of human coronavirus OC43 and NL63 infections in infants, J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol., 53, 135, 10.1016/j.jcv.2011.11.011
Drexler, 2013, Evidence for novel hepaciviruses in rodents, PLoS Pathog., 9, e1003438, 10.1371/journal.ppat.1003438
Drexler, 2012, Bats host major mammalian paramyxoviruses, Nature Commun., 3, 796, 10.1038/ncomms1796
Drosten, 2003, Identification of a novel coronavirus in patients with severe acute respiratory syndrome, New Engl. J. Med., 348, 1967, 10.1056/NEJMoa030747
Drosten, 2013, Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection, Lancet Infect. Dis., 13, 745, 10.1016/S1473-3099(13)70154-3
Ecker, 1996, Overexpression and purification of a recombinant chimeric HIV type 2/HIV type 1 envelope peptide and application in an accelerated immunobased HIV type 1/2 antibody detection system (AIBS): a new rapid serological screening assay, AIDS Res. Hum. Retrovir., 12, 1081, 10.1089/aid.1996.12.1081
Farber, 1993, Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs, J. Virol. Methods, 42, 301, 10.1016/0166-0934(93)90041-O
Fukushi, 2008, Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins, Methods Mol. Biol., 454, 331, 10.1007/978-1-59745-181-9_23
Ge, 2013, Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, Nature, 503, 535, 10.1038/nature12711
Gerna, 1981, Antigenic and biological relationships between human coronavirus Oc43 and neonatal calf diarrhea coronavirus, J. Gen. Virol., 54, 91, 10.1099/0022-1317-54-1-91
Gierer, 2013, The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies, J. Virol., 87, 5502, 10.1128/JVI.00128-13
Gierer, 2013, Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia, Emerg. Infect. Dis., 19, 2034, 10.3201/eid1912.130701
Gorse, 2010, Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum, Clin. Vaccine Immunol., 17, 1875, 10.1128/CVI.00278-10
Grundner, 2004, Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins, Virology, 330, 233, 10.1016/j.virol.2004.08.037
Guan, 2004, Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome, Clin. Diagn. Lab. Immunol., 11, 699, 10.1128/CDLI.11.4.699-703.2004
Guan, 2004, Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients, Clin. Diagn. Lab. Immunol., 11, 287, 10.1128/CDLI.11.2.287-291.2004
Guan, 2004, Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome, Clin. Diagn. Lab. Immunol., 11, 1148, 10.1128/CDLI.11.6.1148-1153.2004
Guan, 2003, Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China, Science, 302, 276, 10.1126/science.1087139
Guery, 2013, Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission, Lancet, 381, 2265, 10.1016/S0140-6736(13)60982-4
Haagmans, 2013, Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation, Lancet Infect. Dis., 14, 140, 10.1016/S1473-3099(13)70690-X
He, 2004, Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome, Clin. Diagn. Lab. Immunol., 11, 417, 10.1128/CDLI.11.2.417-422.2004
He, 2004, Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines, J. Immunol., 173, 4050, 10.4049/jimmunol.173.6.4050
Hofmann, 2004, S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients, J. Virol., 78, 6134, 10.1128/JVI.78.12.6134-6142.2004
Hofmann, 2005, Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry, Proc. Natl. Acad. Sci. U.S.A., 102, 7988, 10.1073/pnas.0409465102
Horzinek, 1982, Antigenic relationships among homologous structural polypeptides of porcine, feline, and canine coronaviruses, Infect. Immun., 37, 1148, 10.1128/IAI.37.3.1148-1155.1982
Hpa, 2013, Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 18, 20427
Hsueh, 2003, Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan, Emerg. Infect. Dis., 9, 1163, 10.3201/eid0909.030367
Isaacs, 1983, Epidemiology of coronavirus respiratory infections, Arch. Dis. Child., 58, 500, 10.1136/adc.58.7.500
Ithete, 2013, Close relative of human middle East respiratory syndrome coronavirus in bat, South Africa, Emerg. Infect. Dis., 19, 1697, 10.3201/eid1910.130946
Kan, 2005, Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms, J. Virol., 79, 11892, 10.1128/JVI.79.18.11892-11900.2005
Ksiazek, 2003, A novel coronavirus associated with severe acute respiratory syndrome, New Engl. J. Med., 348, 1953, 10.1056/NEJMoa030781
Larson, 1980, Isolation of rhinoviruses and coronaviruses from 38 colds in adults, J. Med. Virol., 5, 221, 10.1002/jmv.1890050306
Lau, 2005, Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats, Proc. Natl. Acad. Sci. U.S.A., 102, 14040, 10.1073/pnas.0506735102
Leung, 2004, Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid, J. Infect. Dis., 190, 379, 10.1086/422040
Li, 2005, Bats are natural reservoirs of SARS-like coronaviruses, Science, 310, 676, 10.1126/science.1118391
Liu, 2004, Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients, Clin. Diagn. Lab. Immunol., 11, 227, 10.1128/CDLI.11.1.227-228.2004
Maache, 2006, False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV, Clin. Vaccine Immunol., 13, 409, 10.1128/CVI.13.3.409-414.2006
Manopo, 2005, Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV, J. Immunol. Methods, 296, 37, 10.1016/j.jim.2004.10.012
McIntosh, 1969, Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses, J. Immunol., 102, 1109, 10.4049/jimmunol.102.5.1109
Memish, 2013, Middle East respiratory syndrome coronavirus in bats, Saudi Arabia, Emerg. Infect. Dis., 19, 10.3201/eid1911.131172
Meyer, 2014, Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013. Emerging infectious diseases, 20, 552
Monto, 1974, Medical reviews. Coronaviruses, Yale J. Biol. Med., 47, 234
Muller, 2007, Coronavirus antibodies in African bat species, Emerg. Infect. Dis., 13, 1367, 10.3201/eid1309.070342
Murphy, 2008, 400
Narayanan, 2008, SARS coronavirus accessory proteins, Virus Res., 133, 113, 10.1016/j.virusres.2007.10.009
Neuman, 2008, Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3, J. Virol., 82, 5279, 10.1128/JVI.02631-07
Niedrig, 2005, First external quality assurance of antibody diagnostic for SARS-new coronavirus, J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol., 34, 22, 10.1016/j.jcv.2005.01.004
Patrick, 2006, An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus, Journal canadien des maladies infectieuses et de la microbiologie medicale/AMMI Canada, 17, 330
Peel, 2013, Use of cross-reactive serological assays for detecting novel pathogens in wildlife: assessing an appropriate cutoff for henipavirus assays in African bats, J. Virol. Methods, 193, 295, 10.1016/j.jviromet.2013.06.030
Peiris, 2003, Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361, 1319, 10.1016/S0140-6736(03)13077-2
Perera, 2013, Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 18
Pfefferle, 2009, Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana, Emerg. Infect. Dis., 15, 1377, 10.3201/eid1509.090224
Poon, 2005, Identification of a novel coronavirus in bats, J. Virol., 79, 2001, 10.1128/JVI.79.4.2001-2009.2005
Puzelli, 2013, Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 18
Qiu, 2005, Antibody responses to individual proteins of SARS coronavirus and their neutralization activities, Microbes Infect./Institut Pasteur, 7, 882, 10.1016/j.micinf.2005.02.006
Quan, 2010, Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria, mBio, 1, 10.1128/mBio.00208-10
Reusken, 2013, Specific serology for emerging human coronaviruses by protein microarray, Euro surveillance: bulletin Europeen sur les maladies transmissibles, 18, 20441, 10.2807/1560-7917.ES2013.18.14.20441
Reusken, 2013, Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study, Lancet Infect. Dis., 13, 859, 10.1016/S1473-3099(13)70164-6
Rota, 2003, Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science, 300, 1394, 10.1126/science.1085952
Schaecher, 2007, The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles, J. Virol., 81, 718, 10.1128/JVI.01691-06
Shi, 2003, Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay, J. Clin. Microbiol., 41, 5781, 10.1128/JCM.41.12.5781-5782.2003
Tam, 2002, Influenza A (H5N1) in Hong Kong: an overview, Vaccine, 20, S77L 81
Tan, 2004, Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers, Clin. Diagn. Lab. Immunol., 11, 362, 10.1128/CDLI.11.2.362-371.2004
Tu, 2004, Antibodies to SARS coronavirus in civets, Emerg. Infect. Dis., 10, 2244, 10.3201/eid1012.040520
Wang, 2005, Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients, DNA Cell Biol., 24, 521, 10.1089/dna.2005.24.521
Wang, 2004, Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot, Clin. Immunol., 113, 145, 10.1016/j.clim.2004.07.003
Watts, 2004, China culls wild animals to prevent new SARS threat, Lancet, 363, 134, 10.1016/S0140-6736(03)15313-5
WHO, 2004, vol. 2013
WHO, 2014
Woo, 2004, Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia, Lancet, 363, 841, 10.1016/S0140-6736(04)15729-2
Woo, 2004, Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus, Clin. Diagn. Lab. Immunol., 11, 665, 10.1128/CDLI.11.4.665-668.2004
Woo, 2005, Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia, J. Clin. Microbiol., 43, 3054, 10.1128/JCM.43.7.3054-3058.2005
Wu, 2004, Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan, Emerg. Infect. Dis., 10, 304, 10.3201/eid1002.030731
Yam, 2003, Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus, J. Clin. Microbiol., 41, 4521, 10.1128/JCM.41.10.4521-4524.2003
Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, New Engl. J. Med., 367, 1814, 10.1056/NEJMoa1211721